$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical compositions and methods for insulin treatment 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-038/28
  • A61K-051/00
  • A61M-036/14
출원번호 UP-0509417 (2006-08-24)
등록번호 US-7651996 (2010-02-24)
발명자 / 주소
  • Gyurik, Robert J.
  • Reppucci, Carl
출원인 / 주소
  • CPEX Pharmaceuticals, Inc.
대리인 / 주소
    Davitz, Michael A.
인용정보 피인용 횟수 : 0  인용 특허 : 129

초록

Compositions and methods for treating a patient with insulin that combines insulin, a permeation enhancer, and a carrier that maintains an acidic pH, are disclosed.

대표청구항

We claim: 1. A pharmaceutical composition in a form suitable for nasal delivery to a patient comprising about 1 wt. % insulin, 2 wt. % cyclopentadecanolide, 1% wt. cottenseed oil, 0.6 wt. % Sorbitan, 0.7 wt. % Polysorbate 20, 94.3 wt. % water and buffer amounts of 0.3 wt. % citric acid (monohydrate

이 특허에 인용된 특허 (129)

  1. Sun Ying ; Liu Jue-Chen ; Kimbleton Elizabeth ; Wang Jonas C. T., Acidified composition for topical treatment of nail and skin conditions.
  2. Hedgpeth, Daniel L.; Nicholson, William S. C.; Narang, Upvan; Sherbondy, Anthony; Szabo, Gabriel N., Adhesive treatment for tinea corporis.
  3. Narang, Upvan; Nicholson, William S. C.; Sherbondy, Anthony; Szabo, Gabriel N., Adhesive treatment for tinea cruris.
  4. Bodmer, David; Kissel, Thomas; Richter, Friedrich; Tiemessen, Harry, Allylamine-containing liposomes.
  5. Archer Heidi K. ; Pettit Mitchell S., Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery.
  6. Langla Bernard (Paris FRX) Mondet Jean (Drancy FRX) Papantoniou Christos (Montmorency FRX), Anhydrous nail varnishes.
  7. Meingassner Josef Gottfried,ATX ; Ryder Neil Stewart,ATX, Antifungal composition.
  8. Kamishita Takuzo,JPX ; Miyazaki Takashi,JPX, Antifungal composition for external use being retentive in stratum corneum.
  9. Toshiaki Kamimura JP; Tsuguo Yabuta JP; Saburo Obata JP, Antifungal compositions.
  10. Onishi Janet C. (Mountainside NJ) Patchett Arthur A. (Westfield NJ), Antifungal compositions and method of controlling mycotic infections.
  11. Carlos M. Samour, Antifungal nail lacquer and method using same.
  12. Samour Carlos M. ; Krauser Scott F., Antifungal nail lacquer and method using same.
  13. Sun Ying (Somerville NJ) Liu Jue-Chen (Neshanic NJ) Kimbleton Elizabeth S. (Princeton NJ) Wang Jonas C. T. (Robbinsville NJ), Antifungal treatment of nails.
  14. Laugier Jean-Pierre (Antony FRX) Ringenbach Francois (Bagneu FRX) Touzan Philippe (Vanves FRX), Antifungus composition in dry spray form.
  15. Ferro Alberto (Riehen CHX) Gerhards Jrgen (Arlesheim CHX) Werner Roland (Basle CHX), Antimicotic nail varnish containing amorolfine in quaternary ammonium acrylic copolymer.
  16. Chodosh Daniel Frank (Meadowbrook PA), Antimicrobial compositions and methods for using the same.
  17. Bohn Manfred (Hofheim am Taunus DEX) Dittmar Walter (Hofheim am Taunus DEX) Peil Heinz G. (Bad Nauheim DEX) Futterer Eberhard (Kelkheim DEX) Kraemer Karl (Langen DEX), Antimycotic nail varnish.
  18. Yu Ruey J. ; Van Scott Eugene J., Antiodor, antimicrobial and preservative compositions and methods of using same.
  19. Sekins K. Michael (San Diego CA) Shaffer Thomas H. (Lansdowne PA) Wolfson Marla R. (Wyndmoor PA), Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation.
  20. Michaelis Uwe,DEX ; Rudolph Rainer,DEX ; Winter Gerhard,DEX ; Woog Heinrich,DEX, Aqueous pharmaceutical preparations of G-CSF with a long shelf life.
  21. Franz Thomas J. (Watchung NJ) Shah Kishore R. (Bridgewater NJ) Kydonieus Agis (Kendall Park NJ), Article for the delivery to animal tissue of a pharmacologically active agent.
  22. Kirschner, Mitchell I.; Levinson, R. Saul; Riley, Thomas C.; Hermelin, Marc S., Bioadhesive drug delivery system.
  23. Gould, Robert L.; Whelan, Ian Peter, Body protection article having a gelatinous material with a therapeutic additive.
  24. Yamamoto Nakayuki (Shizuoka JPX) Sugimoto Michihiko (Numazu JPX) Sakakibara Hideo (Mishima JPX) Saita Masaru (Saga JPX) Shimozono Yuji (Tosu JPX) Manako Takafumi (Saga JPX), Calcitonin-containing emulsion for nasal administration.
  25. Bjrklund Knut B. (Bromma SEX), Cancer associated polypeptide antigen compositions.
  26. Raad Issam ; Sherertz Robert, Chelators in combination with biocides: treatment of microbially induced biofilm and corrosion.
  27. Patrick W. Gray ; Larry W. Tjoelker, Chitinase chitin-binding fragments.
  28. Holladay Leslie A. ; Treat-Clemons Lynda G. ; Bassett Patricia Margaret, Composition and method for enhancing electrotransport agent delivery.
  29. Sorenson James L. ; Petersen Robert V., Composition and method for treating diseased nails.
  30. Samour Carlos M. ; Krauser Scott F. ; Gyurik Robert J., Composition and method for treating penile erectile dysfunction.
  31. Sun Ying ; Liu Jue-Chen ; Kimbleton Elisabeth S. ; Wang Jonas C. T., Composition base for topical therapeutic and cosmetic preparations.
  32. Vroom, Rene Werenfridus Lodewijk, Composition for the treatment of hoof conditions in hoofed animals.
  33. Feng-Jing Chen ; Mahesh V. Patel, Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents.
  34. Odds Frank Christopher,BEX ; Embrechts Roger Carolus Augusta,BEX ; De Doncker Piet Richard Gudula,BEX, Compositions containing an antifungal and a cationic agent.
  35. Odds, Frank Christopher; Embrechts, Roger Carolus Augusta; De Doncker, Piet Richard Gudula, Compositions containing an antifungal and a cationic agent.
  36. Trevino Leo A. (San Diego CA) Dellamary Luis A. (San Marcos CA) Tarara Thomas E. (San Diego CA) Weers Jeffry G. (San Diego CA) Ranney Helen M. (La Jolla CA), Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents.
  37. Rampal, Ashok; Raghuvanshi, Rajeev S.; Kumar, Manoj, Controlled release formulation.
  38. Kamber Bruno (Arlesheim CHX), Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use.
  39. Bard Martin, DNA encoding sterol methyltransferase.
  40. Grollier Jean-Fran.cedilla.ois,FRX ; Allec Josiane,FRX ; Agostini Isabelle,FRX, Dermatological/pharmaceutical compositions comprising volatile oils/phenylated silicone oils.
  41. Raad Issam ; Sheretz Robert ; Hachem Ray, EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections.
  42. Raad, Issam; Sherertz, Robert; Hachem, Ray, EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections.
  43. Rudolph James M., File with sanitizing agent.
  44. Rudolph James M., File with sanitizing agent and method.
  45. Randall McCoy ; Miles Augustus Libbey, III ; Jle Liu ; Robert O. Williams, III, Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same.
  46. Onishi Janet C. (Mountainside NJ) Patchett Arthur A. (Westfield NJ), Fungicidal compositions and method.
  47. Berger Vivian ; Heydel Jochen ; Williams Virgil A. G. ; Frihart Charles R. ; Gordon Ronald L. ; MacQueen Richard C. ; Pavlin Mark S., Gels including bioactive components.
  48. Mann Morris A., Hair regeneration compositions for treatment of alopecia and methods of application related thereto.
  49. Samour Carlos M. ; Krauser Scott F. ; Gyurik Robert J., Hormone replacement therapy drug formulations for topical application to the skin.
  50. Clavenna Gaetano (Milan ITX) Poletti Giorgio (Milan ITX), Hydrophilic pharmaceutical composition containing ketoprofen lysine salt for topical use.
  51. Gonda, Igor; Rubsamen, Reid M.; Farr, Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  52. Enever Robin P. (Rouses Point NY) Leonard Thomas W. (Plattsburgh NY) Mikula Karol K. (Morrisonville NY), Insulin administration using methyl and propyl paraben.
  53. Cohen Robert S. (New York NY) Pierce James M. (Coral Gables FL) Kinsey William H. (Coral Gables FL), Intra-vaginal device and method.
  54. Cohen Robert S. (New York NY) Pierce James M. (Coral Gables FL) Kinsey William H. (Coral Gables FL), Intra-vaginal device and method for sustained drug release.
  55. Friedman Michael (Jerusalem ILX) Sintov Amnon (Jerusalem ILX), Liquid polymer composition, and method of use.
  56. Verhoff, Frank H.; Snow, Robert A.; Pace, Gary W., Media milling.
  57. Schutt Ernest G. (San Diego CA), Method and apparatus for partial liquid ventilation or fluorocarbons.
  58. DesMarais Thomas A. (Norwood OH) Stone Keith J. (Fairfield OH), Method for hydrophilizing absorbent foam materials using sorbitan monolaurate.
  59. Hase, Tadashi; Murase, Takatoshi; Watanabe, Hiroyuki; Kondo, Hidehiko, Method for improving insulin resistance.
  60. Jensen Steen,DKX ; Hansen Philip,DKX, Method for producing powder formulation comprising an insulin.
  61. Gadebusch Hans H. (Yardley PA) Valiant Mary E. (Plainfield NJ), Method of controlling mycotic infections and compositions therefor.
  62. Clavenna Gaetano (Rho Milano ITX) Poletti Giorgio (Milan ITX), Method of reducing subcutaneous inflammation by the topical application of a hydrophilic pharmaceutical composition cont.
  63. Kenneth I. Sawyer, Method of treating nail fungus.
  64. Daniel Glassman, Method of treating onychomycosis.
  65. Hubbell, Jeffrey A.; Winblade, Natalie D.; Elbert, Donald L., Methods and compositions to prevent formation of adhesions in biological tissues.
  66. Ponikau Jens, Methods and materials for treating and preventing inflammation of mucosal tissue.
  67. Ponikau Jens, Methods and materials for treating and preventing inflammation of mucosal tissue.
  68. Ponikau, Jens, Methods and materials for treating and preventing inflammation of mucosal tissue.
  69. Karimian Khashayar,CAX ; Leung-Toung Regis C. H. S.,CAX ITX L5N 3X1 ; Li Yiwei,CAX ITX M9B 6K4 ; Tam Tim Fat,CAX ITX L4L 8X6, Methods for the manufacture of terbinafine.
  70. Vyden, John K., Methods for treating atopic disorders.
  71. Peterson Theresa C.,CAX, Methods for treating fibroproliferative diseases.
  72. Sakai Kirk (Coral Springs FL) Quick Timothy W. (Pembroke Pines FL), Moisturizing skin preparation.
  73. Stoltz Edwin I., Nasal administration of drugs.
  74. Hansen Philip E. (Copenhagen DKX) Sorensen Anders R. (Herlev DKX), Nasal formulation and intranasal administration therewith.
  75. Daniels, John R.; Pike, Malcolm C.; Spicer, Darcy V.; Daniels, AnnaMarie, Nasal spray formulation and method.
  76. Yanagawa Akira,JPX, Nasally administrable compositions containing physiologically active peptides.
  77. Samour Carlos M. ; Krauser Scott F. ; Gyurik Robert J., Non-steroidal antiinflammtory drug formulations for topical application to the skin.
  78. Allec Josiane (Antibes FRX) Ferrara Eve (Le Cannet FRX) Bara Isabelle (Paris FRX), Nongreasy/nonsticky fatty cosmetic/dermatological compositions.
  79. Ruey J. Yu ; Eugene J. Van Scott, Oligosaccharide aldonic acids and their topical use.
  80. Friedman Michael (Jerusalem ILX), Oral antifungal preventative, and method of use.
  81. Faithfull Nicholas S. (Normanton by Bottesford CA GB2) Weers Jeffry G. (San Diego CA), Partial liquid breathing of fluorocarbons.
  82. Allen, David M, Penetrating antibiotic gel for soft tissue diseases.
  83. Fuhrman Bradley P. (Pittsburgh PA), Perfluorocarbon associated gas exchange.
  84. Richter Friedrich,CHX ; Roser Marianne,CHX, Pharmaceutical composition.
  85. Richter Friedrich,CHX ; Roser Marianne,CHX, Pharmaceutical composition.
  86. Richter Friedrich,CHX ; Roser Marianne,CHX, Pharmaceutical composition.
  87. Richter Friedrich,CHX ; Steiger Michel,CHX, Pharmaceutical composition.
  88. Richter Friedrich,CHX ; Steiger Michel,CHX, Pharmaceutical composition.
  89. Richter Friedrich,CHX ; Steiger Michel,CHX, Pharmaceutical composition.
  90. Hirai Shin-ichiro (Kyoto JPX) Okada Hiroaki (Suita JPX) Yashiki Takatsuka (Takarazuka JPX), Pharmaceutical composition and its nasal or vaginal use.
  91. Sato Makoto,JPX ; Kouzaki Toshiyuki,JPX ; Ishihara Yoko,JPX ; Yoshina Shigeaki,JPX ; Nakoshi Masanao,JPX ; Maeda Tatsushi,JPX, Pharmaceutical composition containing biologically active peptide or protein.
  92. Richter Friedrich (Schonbuhl CHX) Steiger Michel (Bern CHX), Pharmaceutical composition for topical applications.
  93. Gyurik,Robert J.; Reppucci,Carl, Pharmaceutical compositions and methods for insulin treatment.
  94. Howard Murad, Pharmaceutical compositions and methods for managing skin conditions.
  95. Modi, Pankaj, Pharmaceutical compositions for buccal delivery of pain relief medications.
  96. Ma, Xin Fang, Pharmaceutical formulation for nasal administration.
  97. Patel, Rajesh S.; Srinivasan, Sudarsan, Pore structures for reduced pressure aerosolization.
  98. Straub, Julie; Bernstein, Howard; Chickering, III, Donald E.; Khattak, Sarwat; Randall, Greg, Porous drug matrices and methods of manufacture thereof.
  99. Suzuki Yoshiki (Tokyo JPX) Sekine Kunio (Tokyo JPX) Nagai Tsuneji (Tokyo JPX) Nambu Naoki (Kanagawa JPX) Nishimoto Yuji (Tokyo JPX), Powdery pharmaceutical composition for nasal administration.
  100. Lee, Tai-Au; Wang, Kyu-Jung; Kim, Hong-Bae; Kwon, Kyoung-Chan; Ku, Chang-Hoe, Process for preparing terbinafine and HCI salt thereof.
  101. Castaldi, Graziano; Barreca, Giuseppe; Rossi, Renzo, Process for the preparation of terbinafine.
  102. Stuetz Anton (Maria Enzersdorf ATX), Propenylamines, pharmaceutical compositions containing them and their use as pharmaceuticals.
  103. Stuetz Anton (Maria Enzersdorf ATX), Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuti.
  104. Carl R. Thornfeldt, Pyridine-thiols for treatment of a follicular dermatosis.
  105. Oeltgen, Peter R.; Kindy, Mark S., Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury.
  106. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions.
  107. Miranda Jesus ; Sablotsky Steven, Solubility parameter based drug delivery system and method for altering drug saturation concentration.
  108. Miranda Jesus ; Sablotsky Steven, Solubility parameter based drug delivery system and method for altering drug saturation concentration.
  109. Luis A. Dellamary ; Thomas E. Tarara ; Alexey Kabalnov ; Jeffry G. Weers ; Ernest G. Schutt, Stabilized bioactive preparations and methods of use.
  110. Friedman Doron (Carmei Yosef ILX) Schwarz Joseph (Rehovot ILX) Amselem Shimon (Rehovot ILX), Submicron emulsions for delivery of peptides.
  111. Guerry Philippe (Basel CHX) Jolidon Synse (Birsfelden CHX) Zurflh Ren (Blach CHX), Substituted aminoalkoxybenzene anti-fungicidal compositions and use.
  112. Park Chang-Kyu,KRX ; Choi Jae-Keun,KRX ; Lee Kwang-Ho,KRX ; Hyun Byong-Chul,KRX ; Ha Yi-Dan,KRX, Sustained/immediate acting ketoprofen patch and process for manufacturing the same.
  113. Schuster, Jeffrey A.; Rosell, Joan; Eliahu, Avi; Flaim, Christopher J., Temperature controlling device for aerosol drug delivery.
  114. Brehove, James Edward, Topical application for treating toenail fungus.
  115. Farmer, Sean, Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil.
  116. Crandall Wilson Trafton, Topical moisturizing composition and method.
  117. Hsieh Dean, Transdermal and trans-membrane delivery compositions.
  118. Hseih Dean (Brandamore PA), Transdermal and trans-membrane delivery of drugs.
  119. Grasela John C. ; Grasela Joseph E. ; Jubenville Robert M. ; McCloskey Joseph J., Transdermal delivery of medications using a combination of penetration enhancers.
  120. Whittemore Marilyn S., Treatment of fungal infections using a combination of an anti-fungal compound and an H-alkyl heterocyclic compound.
  121. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents.
  122. Lindley Ivan James Dalton,ATX ; Ryder Neil Stewart,ATX, Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicoba.
  123. Farmer, Sean, Use of emu oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations.
  124. Laugier Jean-Pierre,FRX ; Rude Marie-France,FRX ; Touzan Philippe,FRX ; Rigenbach Fran.cedilla.ois,FRX, Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and correspondi.
  125. Jean-Pierre Laugier FR; Marie-France Rude FR; Philippe Touzan FR; Fran.cedilla.ois Rigenbach FR, Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions.
  126. Laugier Jean-Pierre,FRX ; Rude Marie-France,FRX ; Touzan Philippe,FRX ; Rigenbach Francois,FRX, Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions.
  127. Hassan, Jomaa, Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections.
  128. Guerry Philippe (Basel CHX) Jolidon Synse (Birsfelden CHX) Zurflh Ren (Blach CHX), Use of substituted aminoalkoxybenzene derivatives in the control or prevention of fungal infections.
  129. De Simone Claudio,ITX ; Contini Carlo,ITX ; Tzoutzoglou Sonia,ITX, Use of terbinafine for the therapeutic treatment of pneumocystosis.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로